DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Ajanta Pharma Limited — Analyst/Investor Meet Para A-XBRL

NSE 1 hr ago·15 Oct 2026, 10:56 am

Ajanta Pharma

Ajanta Pharma has informed stock exchanges that it will host an analyst or institutional investor meeting. This announcement signals the company's intent to engage with the financial community to discuss its performance and future outlook.

For investors, such meetings are important as they provide a platform for management to share strategic insights and address queries directly. This transparency helps the market assess the company's direction and operational health beyond standard financial reports.

Investors should watch for updates on the company's guidance, product pipeline, and market expansion plans that may be discussed during the session. Keeping an eye on the official press release will help you stay informed.